Toshinari Takamura

Professor

Kanazawa University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Toshinari Takamura is a faculty member at Kanazawa University in Japan. His research areas encompass the evaluation of treatment effects in clinical trials, the role of the cysteine redoxome in metabolism, and the implications of cystatin C in predicting cardiovascular diseases. He has contributed significantly to studies on diabetes, metabolic disorders, and imaging in hereditary conditions.

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

JAPAN

View details

Shigefumi Okamoto

Professor

Osaka University

JAPAN

View details

Kiyo-aki Ishii

Kanazawa University

JAPAN

View details

Takayuki Kannon

Associate Professor

Fujita Health University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Toshinari Takamura

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Evaluating treatment effect modifiers using data from randomized two-sequence, two-period crossover clinical trials: application to a diabetes study

Cysteine redoxome landscape in mouse brown adipose tissue under acute cold exposure

Thyroid Arteriovenous Malformation in Hereditary Hemorrhagic Telangiectasia: Insights on Successful Noninvasive Imaging

Reductions in liver enzymes are associated with anti‐hyperglycaemic and anti‐obesity effects of tofogliflozin in people with type 2 diabetes: Post‐hoc analyses

Metastatic Pheochromocytoma/Paraganglioma Overproducing Multiple Catecholamines

Association between Bone Mineral Density and Oral Frailty on Renal Function: Findings from the Shika Study

Cystatin C‐based eGFR predicts cardiovascular disease in patients with overweight/obesity and hyperglycemia

Insulin Suppresses Ubiquitination via the Deubiquitinating Enzyme Ubiquitin-Specific Protease 14, Independent of Proteasome Activity in H4IIEC3 Hepatocytes

Circulating selenoprotein P levels predict glucose‐lowering and insulinotropic effects of metformin, but not alogliptin: A post‐hoc analysis

Cystatin C‐based eGFR predicts cardiovascular disease in patients with overweight/obesity and hyperglycemia

GHS-R1a deficiency mitigates lipopolysaccharide-induced lung injury in mice via the downregulation of macrophage activity

Insulin–glucagon‐like peptide‐1 receptor agonist relay and glucagon‐like peptide‐1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open‐label trial study

Cyclosporine A Downregulates Selenoprotein P Expression via a Signal Transducer and Activator of Transcription 3–Forkhead Box Protein O1 Pathway in Hepatocytes In Vitro

Cyclosporine A Downregulates Selenoprotein P Expression via a Signal Transducer and Activator of Transcription 3–Forkhead Box Protein O1 Pathway in Hepatocytes In Vitro

Moderate alcohol consumption is associated with impaired insulin secretion and fasting glucose in non‐obese non‐diabetic men

Collaborators (8)

Fumihiko Suzuki

Hiroyuki NAKAMURA

Yujiro Nakano

Atsushi Tajima

Ryo Emoto

Shigefumi Okamoto

Kiyo-aki Ishii

Takayuki Kannon

Make your next move.